The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1941, 42: 109-116.
Copyright © 1941 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milstone, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Milstone, H.

A Factor in Normal Human Blood which Participates in Streptococcal Fibrinolysis

Haskell Milstone

From the Department of Bacteriology, New York University

Abstract

Fibrinolysin of a group A strain (Co) of hemolytic streptococcus does not exert its characteristic rapid action on human fibrin, if the fibrin is sufficiently pure. Such human fibrin can be rendered susceptible to the fibrinolysin by the addition of a lytic factor present in the euglobulin fraction of normal human serum. The human lytic factor also renders preformed rabbit fibrin susceptible to the group A fibrinolysin. The lytic factor contaminates the usual crude fibrin clot but is distinct from thrombin and fibrinogen.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
B. Laursen and Johs. Gormsen
Studies On Fibrinolytic Activity in Normal Persons and Patients With Atherosclerotic Vascular Dis Ease After Physical Activity and Injections of Nicotinic Acid
Angiology, January 1, 1970; 21(7): 486 - 492.
[PDF]


Home page
ANGIOLOGYHome page
Y. I. Misirlioglu and C. W. Lillehei
The Physiologic Enzymes Activating Profibrinolysin To Fibrinolysin, and the Substances Which Inhibit Activation: Localizations, Clinical Importance and Pathogenesis
Angiology, May 1, 1962; 13(5): 185 - 207.
[PDF]


Home page
ANGIOLOGYHome page
P. L. Berry
Fibrinolysis and Atherosclerosis: A Study of the Fibrinolytic Mechanism in Atherosclerotic Heart Disease
Angiology, May 1, 1962; 13(5): 208 - 211.
[PDF]


Home page
ANGIOLOGYHome page
N. C. Whissen, K. M. Moser, and G. C. Hajjar
Diurnal Variation in Plasma Euglobulin Activity and Fibrinogen Levels*{dagger}: Preliminary Report
Angiology, May 1, 1961; 12(5): 160 - 164.
[PDF]


Home page
ANGIOLOGYHome page
E. E. Cliffton
Early Experience With Fibrinolysin
Angiology, August 1, 1959; 10(4): 244 - 252.
[PDF]


Home page
ANGIOLOGYHome page
J. L. Villavicencio and R. Warren
Experience With the Use of Human Fibrinolysin
Angiology, August 1, 1959; 10(4): 263 - 267.
[PDF]


Home page
ScienceHome page
J. H. Ferguson
Nomenclature of Parenteral Proteases
Science, May 9, 1947; 105(2732): 488 - 489.
[PDF]


Home page
ScienceHome page
COMMISSION ON ACUTE RESPIRATORY DISEASES and M. H. KAPLAN
A QUANTITATIVE STUDY OF THE FIBRINOLYSIN-ANTIFIBRINOLYSIN REACTION
Science, February 2, 1945; 101(2614): 120 - 122.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1941 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1941 by The American Association of Immunologists, Inc. All rights reserved.